Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
Barry RockxThijs KuikenSander HerfstTheo BestebroerMart M LamersBas B Oude MunninkDennis de MeulderGeert van AmerongenJudith van den BrandNisreen M A OkbaDebby SchipperPeter van RunLonneke LeijtenReina SikkemaErnst VerschoorBabs E VerstrepenWilly BogersJan A M LangermansChristian DrostenMartje Fentener van VlissingenRon A M FouchierRik L de SwartMarion P G KoopmansBart L HaagmansPublished in: Science (New York, N.Y.) (2020)
The current pandemic coronavirus, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), was recently identified in patients with an acute respiratory syndrome, coronavirus disease 2019 (COVID-19). To compare its pathogenesis with that of previously emerging coronaviruses, we inoculated cynomolgus macaques with SARS-CoV-2 or Middle East respiratory syndrome (MERS)-CoV and compared the pathology and virology with historical reports of SARS-CoV infections. In SARS-CoV-2-infected macaques, virus was excreted from nose and throat in the absence of clinical signs and detected in type I and II pneumocytes in foci of diffuse alveolar damage and in ciliated epithelial cells of nasal, bronchial, and bronchiolar mucosae. In SARS-CoV infection, lung lesions were typically more severe, whereas they were milder in MERS-CoV infection, where virus was detected mainly in type II pneumocytes. These data show that SARS-CoV-2 causes COVID-19-like disease in macaques and provides a new model to test preventive and therapeutic strategies.